𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Survival in ursodeoxycholic acid-treated patients with biliary cirrhosis

✍ Scribed by AM Bonnand; RE Poupon

Book ID
118519667
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
181 KB
Volume
111
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ursodeoxycholic acid inhibits eosinophil
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis
✍ Kiyoshi Yamazaki; Kazuyuki Suzuki; Atsushi Nakamura; Shunichi Sato; Keith D. Lin πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 421 KB πŸ‘ 1 views

Eosinophilia is a distinctive feature of primary biliary cirrhosis (PBC), especially in its early stages. Intriguingly, treatment with ursodeoxycholic acid (UDCA) ameliorates eosinophilia as well as liver tests in patients with PBC. It remains unknown, however, whether eosinophils in PBC patients ar

Ursodeoxycholic acid therapy in primary
Ursodeoxycholic acid therapy in primary biliary cirrhosis
✍ David E. J. Jones; Oliver F. W. James; Margaret F. Bassendine πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 703 KB

BackgroundlAims: A double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) was conducted in 180 patients with primary biliary cirrhosis (PBC) to define the efficacy and safety of UDCA Efficacy was assessed by time to treatment failure defined as death; liver transplantation; histologic